SG Capital Management’s CONMED CNMD Stock Holding History

SG Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-65,842	Closed	-$4.74M	–	82
2020 Q2	$4.74M	Buy	+65,842	New	+$4.58M	0.88%	39

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

SG Capital Management's CNMD Position: Q3 2020 in Review

SG Capital Management sold out of CONMED (CNMD) in Q3 2020, closing a stake of 65,842 shares — an estimated $4.74M sold.

SG Capital Management first reported a position in CNMD in Q2 2020 and held it in 1 quarter. The position peaked at $4.74M in Q2 2020. 240 funds tracked by Wall St. Rank hold CNMD as of Q3 2020.

SG Capital Management reported no remaining CONMED position as of Q3 2020 after selling out during the quarter.
SG Capital Management sold 65,842 CONMED shares in Q3 2020, an estimated $4.74M.
SG Capital Management first reported a position in CONMED in Q2 2020 and held it in 1 quarter.
SG Capital Management's CONMED position peaked at $4.74M in Q2 2020.
240 funds tracked by Wall St. Rank held CONMED as of Q3 2020.

Based on SG Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.